You have 9 free searches left this month | for more free features.

Urgent Revascularization

Showing 1 - 25 of 2,812

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Acute Coronary Syndrome, Coronary Artery Disease Trial in Paris (Novel strategy Aspirin, Conventional strategy

Active, not recruiting
  • Diabetes Mellitus
  • +3 more
  • Novel strategy Aspirin
  • Conventional strategy Aspirin
  • Paris, France
    Department of Cardiology - Lariboisiere Hospital
Jan 2, 2023

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid

Recruiting
  • Carotid Stenosis
  • +4 more
  • Simutaneous (single anaesthesia) carotid artery stenting with MicroNet covered stent (CGuard) and cardiac surgery (CABG or surgical valve replacement / repair procedure)
  • Krakow, Poland
    Department of Cardiac and Vascular Diseases, John Paul II Hospit
Jul 13, 2021

Restenosis After Lower Extremity Endovascular Revascularization

Recruiting
  • Peripheral Artery Disease
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Feb 25, 2023

    Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Arteriosclerosis
    • Hypercholesterolaemia
    • (no location specified)
    Aug 17, 2023

    Coronary Artery Disease, Aortic Valve Stenosis, TAVI Trial in Worldwide (PCI)

    Active, not recruiting
    • Coronary Artery Disease
    • +3 more
    • PCI
    • Aalborg, Denmark
    • +11 more
    Nov 8, 2022

    Myocardial Infarction, Cardiovascular Disease Trial in Worldwide (Cardiovascular Polypill, Treatment Prevention for Secondary

    Completed
    • Myocardial Infarction
    • Cardiovascular Disease
    • Cardiovascular Polypill
    • Treatment Prevention for Secondary CV
    • Praha, Praha 10, Czechia
    • +112 more
    Jun 28, 2022

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Huntsville, Alabama
    • +83 more
    Feb 1, 2023

    Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

    Not yet recruiting
    • Primary Prevention of Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
    • Placebo in 1.5ml
    • (no location specified)
    Feb 13, 2023

    Myocardial Infarction Trial in Bologna, Ferrara, Reggio Emilia (Angiography-guided PCI, Angiography-derived FFR PCI indication

    Not yet recruiting
    • Myocardial Infarction
    • Angiography-guided PCI
    • Angiography-derived FFR PCI indication and planning
    • Bologna, BO, Italy
    • +2 more
    Apr 5, 2023

    Coronary Artery Disease, Heart Failure Systolic Trial (Revascularization by PCI, Revascularization by CABG)

    Not yet recruiting
    • Coronary Artery Disease
    • Heart Failure Systolic
    • Revascularization by PCI
    • Revascularization by CABG
    • (no location specified)
    Jul 13, 2022

    Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of

    Recruiting
    • Stable Ischemic Heart Disease
    • +2 more
    • Medical Assessment
    • Quality of Life Assessment
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jan 30, 2023

    Coronary Atherosclerosis Due to Calcified Coronary Lesion Trial (Non-invasive stress test, Medical treatment without further

    Not yet recruiting
    • Coronary Atherosclerosis Due to Calcified Coronary Lesion
    • Non-invasive stress test
    • Medical treatment without further testing
    • (no location specified)
    Mar 21, 2023

    ST-elevation Myocardial Infarction, Thrombus, Stents Trial in Naples (MGuard net protective coronary stent, Bare-metal stent and

    Completed
    • ST-elevation Myocardial Infarction
    • +2 more
    • MGuard net protective coronary stent
    • Bare-metal stent and manual thrombectomy device
    • Naples, Italy
      Federico II University of Naples
    Mar 15, 2022

    Xience Skypoint Stents in Routine Clinical Practice

    Not yet recruiting
    • Coronary Artery Disease
    • XIENCE Skypoint™ stent
    • Seoul, Korea, Republic of
      Asan Medical Hospital
    Aug 1, 2023

    Ischemic Heart Disease Trial in New York (Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary

    Recruiting
    • Ischemic Heart Disease
    • Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
    • New York, New York
      Gramercy Cardiac Diagnostic Services
    Aug 17, 2021

    Hybrid Coronary Revascularization

    Recruiting
    • Percutaneous Coronary Revascularization
    • +3 more
    • Hybrid Coronary Revascularization
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jun 30, 2022

    Coronary Artery Disease, Plaque, Atherosclerotic Trial in Worldwide (Coronary intervention, Optimal Medical treatment)

    Active, not recruiting
    • Coronary Artery Disease
    • Plaque, Atherosclerotic
    • Coronary intervention
    • Optimal Medical treatment
    • New York, New York
    • +17 more
    Nov 1, 2021

    IRIS- DESyne X2 in the IRIS-DES Registry

    Recruiting
    • Coronary Stenosis
    • +2 more
    • DESyne X2
    • Incheon, Korea, Republic of
    • +5 more
    Dec 11, 2022

    Rotational Atherectomy in Routine Clinical Practice

    Recruiting
    • Atherosclerosis, Coronary
    • Coronary Stenosis
    • Rotational atherectomy
    • Bucheon, Korea, Republic of
    • +7 more
    Dec 12, 2022

    Vascular Access Complication, Radial Artery, Coronary Artery Disease Trial in Chojnice (distal radial artery acess side,

    Completed
    • Vascular Access Complication
    • +4 more
    • distal radial artery acess side
    • conventional radial artery acess side
    • Chojnice, Pomeranian, Poland
      Szpital Specjalistyczny
    Aug 1, 2023

    Myocardial Ischemia, Acute Coronary Syndrome Trial (Eptifibatide (Integrilin), Placebo)

    Completed
    • Myocardial Ischemia
    • Acute Coronary Syndrome
    • Eptifibatide (Integrilin)
    • Placebo
    • (no location specified)
    Feb 7, 2022

    Orsiro™ Drug Eluting Stent in Routine Clinical Practice

    Active, not recruiting
    • Angioplasty, Transluminal, Percutaneous Coronary
    • Coronary Artery Disease
    • Orsiro™ Drug Eluting Stent group
    • Anyang, Korea, Republic of
    • +17 more
    Dec 11, 2022

    Vascular Diseases, Peripheral Artery Disease, Surgery Trial (neuraxial anesthesia)

    Not yet recruiting
    • Vascular Diseases
    • +2 more
    • neuraxial anesthesia
    • (no location specified)
    Sep 27, 2023

    Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Disease Trial in Korea, Republic of (XIENCE

    Active, not recruiting
    • Percutaneous Transluminal Coronary Angioplasty
    • Coronary Artery Disease
    • XIENCE Xpedition/Alpine/Sierra
    • Anyang, Korea, Republic of
    • +25 more
    Dec 12, 2022

    Personalized Antiplatelet Therapy in CAD Patients

    Completed
    • Coronary Artery Disease
      • (no location specified)
      Dec 14, 2021